Hiroyuki Taniguchi
Hiroyuki Taniguchi publishes mostly in Pulmonary and Respiratory Medicine, Physiology and Molecular Biology, on topics such as Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) Research and Pulmonary Hypertension Research and Treatments.
- World rank
- #265,470 of 7,710,434 ranked researchers
- Rank in Japan
- #2,158 of 383,136
- Works
- 374
- Citations
- 20k
- Citations per work
- 54.0
What does Hiroyuki Taniguchi research?
Hiroyuki Taniguchi's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences23161.8%
- Medicine23161.8%
- Everything else12733.9%
- Life Sciences164.3%
- 1Pulmonary and Respiratory Medicine46% of their works
- 2Physiology5% of their works
- 3Molecular Biology4% of their works
- 4Epidemiology4% of their works
- 5Surgery4% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pulmonary Hypertension Research and Treatments
- Lung Cancer Treatments and Mutations
- Systemic Sclerosis and Related Diseases
- Respiratory Support and Mechanisms
- Respiratory and Cough-Related Research
- Sarcoidosis and Beryllium Toxicity Research
Which keywords describe Hiroyuki Taniguchi's research?
The keywords of their largest research topics: Fibrosis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Diagnosis, Management, COPD, spirometry and Treatment Guidelines.
- Cardiac
- Chronic Cough
- Acute Lung Injury
- Autoantibodies
- EGFR Mutations
- Pulmonary Hypertension
- Treatment Guidelines
- COPD
- Diagnosis
- Idiopathic Pulmonary Fibrosis
- Fibrosis
- Interstitial Lung Disease
- Management
- spirometry
- Endothelial Dysfunction
- Right Heart Assessment
- Targeted Therapy
- Systemic Sclerosis
- Mechanical Ventilation
- Cough Reflex Sensitivity
- Sarcoidosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Fibrosis1852 topics
- Idiopathic Pulmonary Fibrosis1551 topic
- Interstitial Lung Disease1551 topic
- Diagnosis992 topics
- Management992 topics
- COPD781 topic
- spirometry781 topic
- Treatment Guidelines752 topics
- Endothelial Dysfunction682 topics
- Pulmonary Hypertension381 topic
- Right Heart Assessment381 topic
- EGFR Mutations371 topic
- Targeted Therapy371 topic
- Autoantibodies301 topic
- Systemic Sclerosis301 topic
- Acute Lung Injury271 topic
- Mechanical Ventilation271 topic
- Chronic Cough231 topic
- Cough Reflex Sensitivity231 topic
- Cardiac211 topic
- Sarcoidosis211 topic
Where does Hiroyuki Taniguchi work?
Hiroyuki Taniguchi's main affiliation in the publication record is Tosei General Hospital, Japan.
How many publications and citations does Hiroyuki Taniguchi have?
OpenAlex counts 374 works and 20,211 citations for Hiroyuki Taniguchi, an h-index of 61, ranking #265,470 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroyuki Taniguchi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.